Research programme: hepatitis B virus therapy - Digital Gene TechnologiesAlternative Names: Hepatitis B virus therapy research programme - Digital Gene Technologies
Latest Information Update: 22 Sep 2006
At a glance
- Originator Digital Gene Technologies
- Mechanism of Action Virus replication inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 08 Aug 2002 Preclinical trials in Hepatitis B in USA (unspecified route)